Arcutis Biotherapeutics Inc’s recent filing unveils that its Former Officer Topper David Joseph acquired Company’s shares for reported $0.61 million on Aug 08 ’25. In the deal valued at $14.58 per share,41,979 shares were bought.
Then, Burnett Patrick bought 3,847 shares, generating $53,989 in total proceeds.
Before that, Topper David Joseph bought 53,187 shares. Arcutis Biotherapeutics Inc shares valued at $797,446 were divested by the Former Officer at a price of $14.99 per share.
Goldman initiated its Arcutis Biotherapeutics Inc [ARQT] rating to a Neutral in a research note published on July 25, 2025; the price target was $18. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late December with a ‘”a Buy”‘ rating. Jefferies began covering ARQT with “Buy” recommendation on August 28, 2024. Mizuho revised its rating on January 03, 2024. It rated ARQT as “a Buy” which previously was an “a Neutral”.
Price Performance Review of ARQT
On Monday, Arcutis Biotherapeutics Inc [NASDAQ:ARQT] saw its stock fall -3.93% to $14.19. Over the last five days, the stock has lost -2.27%. Arcutis Biotherapeutics Inc shares have risen nearly 60.34% since the year began. Nevertheless, the stocks have risen 1.87% over the past one year. While a 52-week high of $17.75 was reached on 03/25/25, a 52-week low of $8.03 was recorded on 02/11/25.
Levels Of Support And Resistance For ARQT Stock
The 24-hour chart illustrates a support level at 13.94, which if violated will result in even more drops to 13.69. On the upside, there is a resistance level at 14.53. A further resistance level may holdings at 14.88.
How much short interest is there in Arcutis Biotherapeutics Inc?
A steep rise in short interest was recorded in Arcutis Biotherapeutics Inc stocks on 2025-07-15, dropping by -1.38 million shares to a total of 17.27 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 18.64 million shares. There was a decline of -7.98%, which implies that there is a negative sentiment for the stock.
